Lantheus Holdings: May Be Time To Buy After Big Correction

Nov. 28, 2022 2:29 AM ETLantheus Holdings, Inc. (LNTH)PNT4 Comments
Gary Bourgeault profile picture
Gary Bourgeault


  • After two years of continuous upward movement in its share price, Lantheus Holdings finally started to correct, dropping by about $33 per share in under 3 months.
  • With a solid quarter and recent good news, I think, for the most part, investors considered everything already priced in and started taking profits.
  • Even including the recent announcement it entered into a licensing deal with PNT for PNT2002 and PNT2003, it failed to support the stock.
  • With the company's prolonged upward growth trajectory and insiders selling off a lot of shares, I think the market is waiting to see if it has any gas left in the tank.
Cancer malignant cells


Lantheus Holdings, Inc. (NASDAQ:LNTH) has been on a tear over the last couple of years, bottoming out at about $9.00 per share in early November 2020, and from there going on a sustainable upward run that culminated in it soaring to a

This article was written by

Gary Bourgeault profile picture
I am a former investment advisor and owner of several businesses. These days I invest only for myself while continuing to write on a variety of financial and economic topics.

Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Recommended For You

Comments (4)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.